NCT06016855View on ClinicalTrials.gov

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

PHASE4RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 28, 2027

Study Completion Date

May 28, 2028

Conditions
Digestive System Neuroendocrine Tumor G1Digestive System Neuroendocrine Tumor G2Metastatic Digestive System Neuroendocrine NeoplasmMetastatic Malignant Neoplasm in the LiverPancreatic Neuroendocrine Tumor G1Pancreatic Neuroendocrine Tumor G2
Interventions
PROCEDURE

Tumor Debulking

Undergo surgical debulking

DRUG

Lutetium Lu 177 Dotatate

Given by IV

PROCEDURE

Computed Tomography

Undergo Computed Tomography

PROCEDURE

Magnetic Resonance Imaging

Undergo Magnetic Resonance Imaging

DRUG

Copper Cu 64 Dotatate

Given by IV

PROCEDURE

Positron Emission Tomography

Undergo Positron Emission Tomography

Trial Locations (1)

37203

RECRUITING

Vanderbilt University/Ingram Cancer Center, Nashville

All Listed Sponsors
lead

Vanderbilt-Ingram Cancer Center

OTHER